Last reviewed · How we verify
NCT04448418
The Impact of COVID-19 Outbreak on Trans-population's Health in Italy
trial testing web based survey in Transgender Persons in 111 participants. Completed in 20 June 2020.
20 June 2020
Quick facts
| Lead sponsor | Unita Complessa di Ostetricia e Ginecologia |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 111 |
| Start date | 20 May 2020 |
| Primary completion | 20 June 2020 |
| Estimated completion | 20 June 2020 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- web based survey
Conditions studied
- Transgender Persons — all drugs for Transgender Persons →
- Coronavirus — all drugs for Coronavirus →
- Coronavirus Infection — all drugs for Coronavirus Infection →
- COVID — all drugs for COVID →
Sponsor
Unita Complessa di Ostetricia e Ginecologia — full company profile →
Who can join
Adults 18 to 100, any sex, with Transgender Persons or Coronavirus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
During the COVID-19 outbreak, it was necessary to remodel the healthcare offer for all categories of subjects in order to minimize unnecessary movements of people while maintaining an adequate level of assistance. This is also true for transgender people, who are periodically requested to come into the clinic for hormonal therapy monitoring and continuation. In our center telemedicine programs dedicated to users have been activated for the remote management of hormone therapy. We use a web-based survey to assess the impact of COVID-19 outbreak on trans-population health and to assess the specific needs of this population in this particular moment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Telemedicine for endocrinological care of transgender subjects during COVID-19 pandemic.
Gava G, Seracchioli R, Meriggiola MC. · · 2020 · cited 11× · PMID 33033058 · DOI 10.1136/ebmental-2020-300201
Verify or expand the search:
- PubMed search for NCT04448418
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Transgender Persons
Currently open trials in the same condition.
- NCT06177600 — TransHealthGUIDE: Transforming Health for Gender-Diverse Young Adults · NA · recruiting
- NCT06832514 — Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons · Phase 4 · recruiting
- NCT05924217 — Gynecology Beyond Gender: Cervical Cancer Screening in Transgender Men in France · active not recruiting
- NCT05116293 — Effect of Testosterone Treatment on Drug Metabolism and Transport · active not recruiting
Other Unita Complessa di Ostetricia e Ginecologia trials
Trials by the same sponsor.
- NCT04545450 — Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04448418 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Unita Complessa di Ostetricia e Ginecologia
- Last refreshed: 29 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04448418.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing